Bio-Connect
Immunohistochemical staining of formalin fixed and paraffin embedded human tonsil tissue section using anti-CD79a rabbit monoclonal antibody (Clone RM297) at a 1:200 dilution.
Immunohistochemical staining of formalin fixed and paraffin embedded human tonsil tissue section using anti-CD79a rabbit monoclonal antibody (Clone RM297) at a 1:200 dilution.
Immunohistochemical staining of formalin fixed and paraffin embedded human tonsil tissue section using anti-CD79a rabbit monoclonal antibody (Clone RM297) at a 1:200 dilution.

anti-CD79a (C-term) (human), Rabbit Monoclonal (RM297)

Research Use Only
REV-31-1182-00
RevMAb Biosciences
ApplicationsWestern Blot, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetCD79A
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    RevMAb Biosciences
  • Product Name
    anti-CD79a (C-term) (human), Rabbit Monoclonal (RM297)
  • Delivery Days Customer
    5
  • Antibody Specificity
    This antibody reacts to human CD79a.
  • Applications
    Western Blot, ImmunoHistoChemistry
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    RM297
  • Formulation
    Liquid
  • Gene ID973
  • Target name
    CD79A
  • Target description
    CD79a molecule
  • Target synonyms
    B-cell antigen receptor complex-associated protein alpha chain; CD79a antigen (immunoglobulin-associated alpha); CD79a molecule, immunoglobulin-associated alpha; IGA; ig-alpha; MB-1; MB-1 membrane glycoprotein; membrane-bound immunoglobulin-associated protein; surface IgM-associated protein
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP11912
  • Protein Name
    B-cell antigen receptor complex-associated protein alpha chain
  • Scientific Description
    CD79a is a disulphide-linked heterodimer together with CD79b. CD79a plays multiple and diverse roles in B cell development and function. The CD79a/b heterodimer associates non-covalently with the immunoglobulin heavy chain through its transmembrane region, thus forming the BCR along with the immunoglobulin light chain and the pre-BCR when associated with the surrogate light chain in developing B cells. Association of the CD79a/b heterodimer with the immunoglobulin heavy chain is required for surface expression of the BCR and BCR induced calcium flux and protein tyrosine phosphorylation. The CD79a protein is present on the surface of B-cells throughout their life cycle, and is absent on all other healthy cells, making it a highly reliable marker for B-cells in immunohistochemistry. The protein remains present when B cells transform into active plasma cells, and is also present in virtually all B-cell neoplasms, including B-cell lymphomas, plasmacytomas and myelomas. It is also present in abnormal lymphocytes associated with some cases of Hodgkins disease. Because even on B cell precursors, it can be used to stain a wider range of cells compared to the alternative B cell marker CD20 and is often used together in immunohistochemistry panels. - Recombinant Antibody. This antibody reacts to human CD79a. Applications: WB, IHC. Source: Rabbit. Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide. CD79a is a disulphide-linked heterodimer together with CD79b. CD79a plays multiple and diverse roles in B cell development and function. The CD79a/b heterodimer associates non-covalently with the immunoglobulin heavy chain through its transmembrane region, thus forming the BCR along with the immunoglobulin light chain and the pre-BCR when associated with the surrogate light chain in developing B cells. Association of the CD79a/b heterodimer with the immunoglobulin heavy chain is required for surface expression of the BCR and BCR induced calcium flux and protein tyrosine phosphorylation. The CD79a protein is present on the surface of B-cells throughout their life cycle, and is absent on all other healthy cells, making it a highly reliable marker for B-cells in immunohistochemistry. The protein remains present when B cells transform into active plasma cells, and is also present in virtually all B-cell neoplasms, including B-cell lymphomas, plasmacytomas and myelomas. It is also present in abnormal lymphocytes associated with some cases of Hodgkins disease. Because even on B cell precursors, it can be used to stain a wider range of cells compared to the alternative B cell marker CD20 and is often used together in immunohistochemistry panels.
  • Reactivity
    Human
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203